[Endothelin receptor antagonism in routine clinical care].
Riemekasten
Gabriele
G
Medizinische Klinik mitSchwerpunkt Rheumatologie und Klinische Immunologie an der Charité, Berlin.
D000077300:Bosentan; D018849:Controlled Clinical Trials as Topic; D017277:Drug Approval; D064420:Drug-Related Side Effects and Adverse Reactions; D065128:Endothelin Receptor Antagonists; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy / Q000401:mortality / Q000451:nursing*; D011379:Prognosis; D012595:Scleroderma, Systemic / Q000188:drug therapy / Q000401:mortality / Q000451:nursing*; D013449:Sulfonamides / Q000009:adverse effects / Q000627:therapeutic use*; D016019:Survival Analysis
D065128:Endothelin Receptor Antagonists; D013449:Sulfonamides; D000077300:Bosentan